These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9271024)

  • 21. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy.
    Niimura H; Bachinski LL; Sangwatanaroj S; Watkins H; Chudley AE; McKenna W; Kristinsson A; Roberts R; Sole M; Maron BJ; Seidman JG; Seidman CE
    N Engl J Med; 1998 Apr; 338(18):1248-57. PubMed ID: 9562578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated beta-myosin heavy chain genes.
    Jeschke B; Uhl K; Weist B; Schröder D; Meitinger T; Döhlemann C; Vosberg HP
    Hum Genet; 1998 Mar; 102(3):299-304. PubMed ID: 9544842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Missense mutation of the beta-cardiac myosin heavy-chain gene in hypertrophic cardiomyopathy.
    Arai S; Matsuoka R; Hirayama K; Sakurai H; Tamura M; Ozawa T; Kimura M; Imamura S; Furutani Y; Joh-o K
    Am J Med Genet; 1995 Sep; 58(3):267-76. PubMed ID: 8533830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy.
    Van Driest SL; Ackerman MJ; Ommen SR; Shakur R; Will ML; Nishimura RA; Tajik AJ; Gersh BJ
    Circulation; 2002 Dec; 106(24):3085-90. PubMed ID: 12473556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygotes for a R869G mutation in the beta -myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy.
    Richard P; Charron P; Leclercq C; Ledeuil C; Carrier L; Dubourg O; Desnos M; Bouhour JB; Schwartz K; Daubert JC; Komajda M; Hainque B
    J Mol Cell Cardiol; 2000 Aug; 32(8):1575-83. PubMed ID: 10900182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy.
    Kabaeva ZT; Perrot A; Wolter B; Dietz R; Cardim N; Correia JM; Schulte HD; Aldashev AA; Mirrakhimov MM; Osterziel KJ
    Eur J Hum Genet; 2002 Nov; 10(11):741-8. PubMed ID: 12404107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
    Blair E; Redwood C; de Jesus Oliveira M; Moolman-Smook JC; Brink P; Corfield VA; Ostman-Smith I; Watkins H
    Circ Res; 2002 Feb; 90(3):263-9. PubMed ID: 11861413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype-phenotype analysis in four families with mutations in beta-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.
    Tesson F; Richard P; Charron P; Mathieu B; Cruaud C; Carrier L; Dubourg O; Lautié N; Desnos M; Millaire A; Isnard R; Hagege AA; Bouhour JB; Bennaceur M; Hainque B; Guicheney P; Schwartz K; Komajda M
    Hum Mutat; 1998; 12(6):385-92. PubMed ID: 9829907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation.
    Tesson F; Dufour C; Moolman JC; Carrier L; al-Mahdawi S; Chojnowska L; Dubourg O; Soubrier E; Brink P; Komajda M; Guicheney P; Schwartz K; Feingold J
    J Mol Cell Cardiol; 1997 Feb; 29(2):831-8. PubMed ID: 9140839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.
    Epstein ND; Cohn GM; Cyran F; Fananapazir L
    Circulation; 1992 Aug; 86(2):345-52. PubMed ID: 1638703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sudden death due to troponin T mutations.
    Moolman JC; Corfield VA; Posen B; Ngumbela K; Seidman C; Brink PA; Watkins H
    J Am Coll Cardiol; 1997 Mar; 29(3):549-55. PubMed ID: 9060892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes.
    Charron P; Dubourg O; Desnos M; Isnard R; Hagege A; Bonne G; Carrier L; Tesson F; Bouhour JB; Buzzi JC; Feingold J; Schwartz K; Komajda M
    Eur Heart J; 1998 Jan; 19(1):139-45. PubMed ID: 9503187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early expression of a malignant phenotype of familial hypertrophic cardiomyopathy associated with a Gly716Arg myosin heavy chain mutation in a Korean family.
    Hwang TH; Lee WH; Kimura A; Satoh M; Nakamura T; Kim MK; Choi SK; Park JE
    Am J Cardiol; 1998 Dec; 82(12):1509-13. PubMed ID: 9874056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Family hypertrophic cardiomyopathy caused by a 14035c > t mutation in cardiac troponin T gene].
    Wang SX; Zou YB; Fu CY; Song L; Wang H; Wang JZ; Song XD; Chen JZ; Hui RT
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):371-4. PubMed ID: 17456375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.
    Ackerman MJ; VanDriest SL; Ommen SR; Will ML; Nishimura RA; Tajik AJ; Gersh BJ
    J Am Coll Cardiol; 2002 Jun; 39(12):2042-8. PubMed ID: 12084606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene.
    Ripoll-Vera T; Gámez JM; Govea N; Gómez Y; Núñez J; Socías L; Escandell Á; Rosell J
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):149-58. PubMed ID: 26507537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.